HR and invasive breast carcinoma: A total of 2,858 patients who underwent CNB and surgery and were diagnosed with HR+/HER2− early invasive breast cancer at the Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine between January 2009 and March 2020 were included in the study (Figure 1).